Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Omikron Italia Logo
Omikron Italia Growth Score
83
CB Rank
1621546
Heat Score
50
Omikron Italia is a pharmaceutical company that develops products and therapeutic responses for the vascular and ophthalmic sectors.
Founded
obfuscation
Private Rome, Lazio, Italy11-50 www.omikronitalia.it
Health Care
Manufacturing
Pharmaceutical
Overview

Omikron Italia
Growth Score
83
Heat Score
50

Growth Score83
-5 pts
in past quarter
Heat Score 50
-22 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Omikron Italia

CB Rank
1621546
Omikron Italia is a pharmaceutical company that develops products and therapeutic responses for the vascular and ophthalmic sectors.
Founded
obfuscation
Private Rome, Lazio, Italy11-50 www.omikronitalia.it
Health Care
Manufacturing
Pharmaceutical

Details

Legal Name Omikron Italy srl
Operating Status Active
Company Type For Profit
Phone Number +39 06 80693572
Contact Email info@omikronitalia.it
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Citicoline Ophthalmic Solutions (OMK1®, OMK2®, OMK1®-LF)
Eye drop formulations containing citicoline, hyaluronic acid, and vitamin B12 designed for neuroprotection and treatment of glaucoma and other ophthalmic neurodegenerative diseases.
CONAN® Proctological Cream
A topical medical device cream formulated for the treatment of hemorrhoidal disease, anal fissures, and related anorectal conditions.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Contacts 5
News
Technology
View Tech Report

Monthly Web Visits

7,039
390.18%
 in past month

IT Spend

$103.4KThis year, Omikron Italia is projected to spend $103.4K on IT, according to Aberdeen.

Active Website Tech Count

3Omikron Italia is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, HSTS, and  CommonCrawl Top 5m.

Total IP

14The intellectual property of Omikron Italia includes 6 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Omikron Italia has registered 8 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Omikron Italia's headquarters? Omikron Italia is located in Rome, Lazio, Italy.Who are Omikron Italia's competitors? Alternatives and possible competitors to Omikron Italia may include AbbVie, Bausch & Lomb, and  Alcon.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|